Buyout Of Gen-Probe - Shareholder Investigation By Tripp Levy PLLC On Behalf Of Gen-Probe Shareholders

News provided by

Apr 30, 2012, 09:08 ET

NEW YORK, April 30, 2012 /PRNewswire/ -- Tripp Levy PLLC, a leading national securities law firm, is investigating the Senior Management and the Board of Directors of Gen-Probe Inc. (NASDAQ: GPRO) for possible breaches of fiduciary duty and other violations of state law. On April 30, 2012, Hologic, Inc. (NASDAQ: HOLX) announced that it has entered into a definitive merger agreement whereby Hologic will acquire all the outstanding shares of Gen-Probe for $82.75 per share in cash.

The investigation concerns, among other things, whether the consideration to be paid to Gen-Probe shareholders is unfair, inadequate, and substantially below the fair or inherent value of Gen-Probe, and whether the senior management of Gen-Probe are putting their own self-interests ahead of that of the Company's shareholders. Indeed, analysts project Gen-Probe's true going forward value is in excess of the merger consideration.

If you own common stock in Gen-Probe and wish to obtain additional information, please contact us at:

Tripp Levy PLLC

Toll free: 877-772-3975

Email: [email protected]

www.tripplevy.com

SOURCE Tripp Levy PLLC